Uric acid does not affect the prevalence and extent of coronary artery disease. Results from a prospective study

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 22, Issue 5, 2012, Pages 426-433

  De Luca, G ^a   Secco, G G ^a   Santagostino, M ^a   Venegoni, L ^a   Iorio, S ^a   Cassetti, E ^a   Verdoia, M ^a   Coppo, L ^a   Di Mario, C ^b   Bellomo, G ^a   Marino, P ^a  

^a UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^b ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

Atherosclerosis; CAD; Hyperuricemia; Uric acid

Indexed keywords

URIC ACID;

AGED; ANGIOCARDIOGRAPHY; ARTERIAL WALL THICKNESS; ARTICLE; BLOOD; COHORT ANALYSIS; CORONARY ARTERY DISEASE; CORONARY BLOOD VESSEL; CROSS-SECTIONAL STUDY; ECHOCARDIOGRAPHY; ECHOGRAPHY; FEMALE; HOSPITALIZATION; HUMAN; HYPERURICEMIA; ITALY; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; PREVALENCE; PROSPECTIVE STUDY; THROMBOCYTE AGGREGATION;

AGED; AGED, 80 AND OVER; CAROTID INTIMA-MEDIA THICKNESS; COHORT STUDIES; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CORONARY VESSELS; CROSS-SECTIONAL STUDIES; ECHOCARDIOGRAPHY; FEMALE; HUMANS; HYPERURICEMIA; ITALY; MALE; MIDDLE AGED; PLATELET AGGREGATION; PREVALENCE; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; URIC ACID;

DELLA;

EID: 84859960120     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.numecd.2010.08.005     Document Type: Article

References (31)

1. Butler R., Morris A.D., Belch J.J., Hill A., Struthers A.D. Allopurinol normalizes endothelial dysfunction in type 2 diabetics with mild hypertension. Hypertension 2000, 35:746-751.
2. Rao G.N., Corson M.A., Berk B.C. Uric acid stimulates vascular smooth muscle cell proliferation by increasing platelet-derived growth factor A-chain expression. J Biol Chem 1991, 266:8604-8608.
3. Beard T. Serum uric acid and coronary heart disease. Am Heart J 1983, 106:397-400.
4. Cook D.G., Shaper A.G., Thelle D.S., Whitehead T.P. Serum uric acid, serum glucose and diabetes: relationships in a population study. Postgrad Med J 1986, 62:1001-1006.
5. Chu N.F., Wang D.J., Liou S.H., Shieh S.M. Relationship between hyperuricemia and other cardiovascular disease risk factors among adult males in Taiwan. Eur J Epidemiol 2000, 16:13-17.
6. De Luca G., van 't Hof A.W., Ottervanger J.P., Hoorntje J.C., Gosselink A.T., Dambrink J.H., et al. Ageing, impaired myocardial perfusion, and mortality in patients with ST-segment elevation myocardial infarction treated by primary angioplasty. Eur Heart J 2005, 26:662-666.
7. Waring W.S., Webb D.J., Maxwell S.R.J. Uric acid as a risk factor for cardiovascular disease. QJM 2000, 93:707-713.
8. Khosla M., Zharikov S., Finch J.L., Nakagawa T., Roncal C., Mu W., et al. Hyperuricemia induces endothelial dysfunction and vasoconstriction. Kidney Int 2005, 67:1739-1742.
9. Kuwahata S., Hamasaki S., Ishida S., Kataoka T., Yoshikawa A., Orihara K., et al. Effect of uric acid on coronary microvascular endothelial function in women: association with eGFR and ADMA. J Atheroscler Thromb 2010, 17:259-269.
10. Rao G.N., Corson M.A., Berk B.C. Uric acid stimulates vascular smooth muscle cell proliferation by increasing platelet-derived growth factor A-chain expression. J Biol Chem 1991, 266:8604-8608.
11. Kanellis J., Watanabe S., Li J.H., Kang D.H., Li P., Nakagawa T., et al. Uric acid stimulates monocyte chemoattractant protein-1 production in vascular smooth muscle cells via mitogen-activated protein kinase and cyclooxygenase-2. Hypertension 2003, 41:1287-1293.
12. Ohtsubo T., Rovira I.I., Starost M.F., Liu C., Finkel T. Xanthine oxidoreductase is an endogenous regulator of cyclooxygenase-2. Circ Res 2004, 95:1118-1124.
13. Cattaneo M. Resistance to antiplatelet drugs: molecular mechanisms and laboratory detection. J Thromb Haemost 2007, 5(Suppl. 1):230-237.
14. Zweier L., Kuppusamy P., Lutty G.A. Measurement of endothelial cell free radical generation: evidence for a central mechanism of free radical injury in postischemic tissues. Proc Natl Acad Sci U S A 1988, 85:4046-4050.
15. Desco M.C., Asensi M., Marquez R., Martinez-Valls J., Vento M., Pallardo F.V., et al. Xanthine oxidase is involved in free radical production in type 1 diabetes: protection by allopurinol. Diabetes 2002, 51:1118-1124.
16. Ricardo S.D., Bertram J.F., Ryan G.B. Podocyte architecture in puromycin aminoglycoside-treated rats administered tungsten or allopurinol. Exp Nephrol 1995, 3:270-279.
17. Becker B.F. Towards the physiological function of uric acid. Free Radic Biol Med 1993, 14:615-631.
18. Nieto F.J., Iribarren C., Gross M.D., Comstock G.W., Cutler R.G. Uric acid and serum antioxidant capacity: a reaction to atherosclerosis?. Atherosclerosis 2000, 148:131-139.
19. Choi H.K., Curhan G. Independent impact of gout on mortality and risk for coronary heart disease. Circulation 2007, 116:894-900.
20. Bickel C., Rupprecht H.J., Blankenberg S., Rippin G., Hafner G., Daunhauer A., et al. Serum uric acid as an independent predictor of mortality in patients with angiographically proven coronary artery disease. Am J Cardiol 2002, 89:12-17.
21. Strasak A.M., Kelleher C.C., Brant L.J., Rapp K., Ruttmann E., Concin H., et al. Serum uric acid is an independent predictor for all major forms of cardiovascular death in 28,613 elderly women: a prospective 21-year follow-up study. Int J Cardiol 2008 Apr 10, 125(2):232-239. VHM&PP Study Group, [Epub 2008 Jan 30].
22. Athyros V.G., Elisaf M., Papageorgiou A.A., Symeonidis A.N., Pehlivanidis A.N., Bouloukos V.I., et al. Effect of statins versus untreated dyslipidemia on serum uric acid levels in patients with coronary heart disease: a subgroup analysis of the GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) study. Am J Kidney Dis 2004 Apr, 43(4):589-599.
23. Kocaman S.A., Sahinarslan A., Cemri M., Timurkaynak T., Boyaci B., Cengel A. Independent relationship of serum uric acid levels with leukocytes and coronary atherosclerotic burden. Nutr Metab Cardiovasc Dis 2009 Dec, 19(10):729-735. [Epub 2009 Aug 22].
24. Brodov Y., Chouraqui P., Goldenberg I., Boyko V., Mandelzweig L., Behar S. Serum uric acid for risk stratification of patients with coronary artery disease. Cardiology 2009, 114:300-305.
25. Culleton B.F., Larson M.G., Kannel W.B., Levy D. Serum uric acid and risk for cardiovascular disease and death: the Framingham Heart Study. Ann Intern Med 1999, 131:7-13.
26. Moriarity J.T., Folsom A.R., Iribarren C., Nieto F.J., Rosamond W.D. Serum acid uric and risk of coronary heart disease: atherosclerosis Risk in Communities (ARIC) study. Ann Epidemiol 2000, 10:136-143.
27. Strasak A., Ruttmann E., Brant L., Kelleher C., Klenk J., Concin H., et al. Serum uric acid and risk of cardiovascular mortality: a prospective long-term study of 83 683 Austrian men. Clin Chem 2008, 54:273-284.
28. Wen C.P., David Cheng T.Y., Chan H.T., Tsai M.K., Chung W.S., Tsai S.P., et al. Is high serum uric acid a risk marker or a target for treatment? Examination of its independent effect in a large cohort with low cardiovascular risk. Am J Kidney Dis 2010 Jun 2.
29. Høieggen A., Alderman M.H., Kjeldsen S.E., Julius S., Devereux R.B., Faire U, et al. The impact of serum uric acid on cardiovascular outcomes in the LIFE study. Kidney Int 2004, 65:1041-1049. LIFE Study Group.
30. Tsai T.H., Chen Y.L., Chen S.M., Yang C.H., Fang C.Y., Hsieh Y.K., et al. Uric Acid is not an independent predictor of cardiovascular death in patients with angiographically proven coronary artery disease. Chang Gung Med J 2009, 32:605-613.
31. Kim S.Y., Guevara J.P., Kim K.M., Choi H.K., Heitjan D.F., Albert D.A. Hyperuricemia and coronary heart disease: a systematic review and meta-analysis. Arthritis Care Res (Hoboken) 2010, 62:170-180.